World-class research delivered on-time and on-budget. You've heard it before. But Clinical Ambassador is next level, where patient recruitment meets DEI, changing the narrative to delivers empowered engagement and real, bona fide reach and representation. We specialize in special populations and cultural competence. Connecting with people to make research meanigful to them where they are. And it happens to be our baileywick and sweet spot. That's our magic.
Clinical Ambassador engages people, creates an atmosphere of confidence, motivation and empowerment, helping industry leverage transparency and trustworthiness to enroll studies reflecting a remit of inclusion.
We are intentional about helping clients build meaningful connections. After all, authenticity is about aligning your values with your actions. It means getting beyond lip-service and platitudes about DEI to build bridges capable of spanning discomfort and misconceptions. Clinical Ambassador's strategic diplomacy optimizes capacity for trustworthiness, leveraging more effective communication about your studies and your brand. You need to be reminding that everything is possible with enough intention and dedicated action behind it.
Clinical Ambassador achieves DEI goals across all therapeutic areas, across cultural divides, and for any end-user. Our specialty is connecting to people and connecting the dots for underrepresented populations you seek to enroll. Our super-specialty is a guarantee of better access to and for "real" people— for representation that optimizes diversity plans in any study.
Clinical Ambassador ensures patient voice in the research design process. We support decentralized trials to ensure the human touch is not lost. We meet underserved populations where they are and prioritize community engagement with a full menu of connectivity solutions. Our DEI strategies are investments in relationships— the foundation of trust and better health outcomes.
Recently, more than 30,000 individuals participated in FDA-approved clinical trials that result in the availability of new drugs. Of those, 29% were women, 7% Hispanic, 3.2% black or African American, and 2% Asian. By contrast, the 2020 US Census confirms that women comprised 51%, Hispanics 18.5%, black or African American 12.2%, and Asians 5.6% of total US population.
People face all types of hurdles when it comes to participating in clinical trials. We also know that these factors—from industry-made to the social determinants of health— contribute directly to underrepresentation and further marginalization. We help mitigate these barriers by identifying opportunities that make it easier for people to participate, on a study-by-study basis, and guarantee that the people who need access most will not be blind to these opportunities. Clinical Ambassador addresses systemic obstacles head-on by providing the following: